Kroger announced that Colleen Lindholz, president of Kroger Health, will retire after more than three decades with the supermarket operator. The leadership change comes as Kroger shares trade at US$58.74, down slightly over the past week, with a 1-year total shareholder return of negative 8.23% but gains of 40.35% over three years and 67.27% over five years. Buybacks completed in 2026, a reaffirmed quarterly dividend, and ongoing product launches such as the seasonal Private Selection Pumpkin Harvest Collection remain in the background as investors weigh the Kroger Health transition against that longer track record. The most followed analysis pegs Kroger's fair value at $65.65, implying the stock is 10.5% undervalued, with the narrative resting on cost discipline holding up even as the sales line missed its guidance range. Kroger's outlook now depends on cost savings and e-commerce profitability holding up if sales soften further, and on October's investor update matching the confident tone of the latest call.
Kroger CompanyKroger Health president Colleen Lindholz to retire after three decades; leadership change with no clear positive or negative driver stated.
